| Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis‐like disease in C57BL/6 mice E Kozela, N Lev, N Kaushansky, R Eilam, N Rimmerman, R Levy, ... British journal of pharmacology 163 (7), 1507-1519, 2011 | 215 | 2011 |
| From classic to spontaneous and humanized models of multiple sclerosis: impact on understanding pathogenesis and drug development A Ben-Nun, N Kaushansky, N Kawakami, G Krishnamoorthy, K Berer, ... Journal of autoimmunity 54, 33-50, 2014 | 190 | 2014 |
| Cannabinoids decrease the th17 inflammatory autoimmune phenotype E Kozela, A Juknat, N Kaushansky, N Rimmerman, A Ben-Nun, Z Vogel Journal of Neuroimmune Pharmacology 8, 1265-1276, 2013 | 137 | 2013 |
| Small molecules co-targeting CKIα and the transcriptional kinases CDK7/9 control AML in preclinical models W Minzel, A Venkatachalam, A Fink, E Hung, G Brachya, I Burstain, ... Cell 175 (1), 171-185. e25, 2018 | 120 | 2018 |
| Daily onset of light and darkness differentially controls hematopoietic stem cell differentiation and maintenance K Golan, A Kumari, O Kollet, E Khatib-Massalha, MD Subramaniam, ... Cell stem cell 23 (4), 572-585. e7, 2018 | 117 | 2018 |
| Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells E Kozela, A Juknat, F Gao, N Kaushansky, G Coppola, Z Vogel Journal of neuroinflammation 13, 1-19, 2016 | 95 | 2016 |
| CCR2 regulates the immune response by modulating the interconversion and function of effector and regulatory T cells E Bakos, CA Thaiss, MP Kramer, S Cohen, L Radomir, I Orr, ... The Journal of Immunology 198 (12), 4659-4671, 2017 | 84 | 2017 |
| The polymer-coated SAW sensor as a gravimetric sensor Z Liron, N Kaushansky, G Frishman, D Kaplan, J Greenblatt Analytical Chemistry 69 (14), 2848-2854, 1997 | 61 | 1997 |
| Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells E Kozela, A Juknat, N Kaushansky, A Ben-Nun, G Coppola, Z Vogel Journal of neuroinflammation 12, 1-16, 2015 | 58 | 2015 |
| Inhomogeneous encoding of the visual field in the mouse retina RA Warwick, N Kaushansky, N Sarid, A Golan, M Rivlin-Etzion Current Biology 28 (5), 655-665. e3, 2018 | 57 | 2018 |
| DQB1* 0602 rather than DRB1* 1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP) N Kaushansky, DM Altmann, CS David, H Lassmann, A Ben-Nun Journal of neuroinflammation 9, 1-15, 2012 | 52 | 2012 |
| The myelin-associated oligodendrocytic basic protein (MOBP) as a relevant primary target autoantigen in multiple sclerosis N Kaushansky, M Eisenstein, R Zilkha-Falb, A Ben-Nun Autoimmunity reviews 9 (4), 233-236, 2010 | 50 | 2010 |
| Anatomy of T cell autoimmunity to myelin oligodendrocyte glycoprotein (MOG): Prime role of MOG44F in selection and control of MOG‐reactive T cells in H‐2b mice A Ben‐Nun, NK de Rosbo, N Kaushansky, M Eisenstein, L Cohen, ... European journal of immunology 36 (2), 478-493, 2006 | 49 | 2006 |
| Post-CNS-inflammation expression of CXCL12 promotes the endogenous myelin/neuronal repair capacity following spontaneous recovery from multiple sclerosis-like disease R Zilkha-Falb, N Kaushansky, N Kawakami, A Ben-Nun Journal of neuroinflammation 13, 1-19, 2016 | 44 | 2016 |
| Anti-inflammatory effects of the cannabidiol derivative dimethylheptyl-cannabidiol–studies in BV-2 microglia and encephalitogenic T cells A Juknat, E Kozela, N Kaushansky, R Mechoulam, Z Vogel Journal of Basic and Clinical Physiology and Pharmacology 27 (3), 289-296, 2016 | 44 | 2016 |
| Epitope specificity of autoreactive T and B cells associated with experimental autoimmune encephalomyelitis and optic neuritis induced by oligodendrocyte-specific protein in … N Kaushansky, MC Zhong, N Kerlero de Rosbo, R Hoeftberger, ... The Journal of Immunology 177 (10), 7364-7376, 2006 | 39 | 2006 |
| A highly conserved sequence associated with the HIV gp41 loop region is an immunomodulator of antigen-specific T cells in mice A Ashkenazi, O Faingold, N Kaushansky, A Ben-Nun, Y Shai Blood, The Journal of the American Society of Hematology 121 (12), 2244-2252, 2013 | 34 | 2013 |
| HU‐446 and HU‐465, Derivatives of the Non‐psychoactive Cannabinoid Cannabidiol, Decrease the Activation of Encephalitogenic T Cells E Kozela, C Haj, L Hanuš, M Chourasia, A Shurki, A Juknat, ... Chemical biology & drug design 87 (1), 143-153, 2016 | 33 | 2016 |
| HLA-DQB1* 0602 determines disease susceptibility in a new “humanized” multiple sclerosis model in HLA-DR15 (DRB1* 1501; DQB1* 0602) transgenic mice N Kaushansky, DM Altmann, S Ascough, CS David, H Lassmann, ... The Journal of Immunology 183 (5), 3531-3541, 2009 | 32 | 2009 |
| ‘Multi-epitope-targeted’immune-specific therapy for a multiple sclerosis-like disease via engineered multi-epitope protein is superior to peptides N Kaushansky, N Kerlero de Rosbo, R Zilkha-Falb, R Yosef-Hemo, ... PLoS One 6 (11), e27860, 2011 | 28 | 2011 |
Liran ShlushWeizmann Institute of ScienceVerified email at weizmann.ac.il
